Neptune Technologies & Bioressources Inc.: Form 6-K - Prepared by TNT Filings Inc.

SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549
  
FORM 6-K
 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

 

For the month of: November, 2008

 Commission File Number:  001-33526

NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.

(Name of Registrant)

 

225 Promende du Centropolis

Suite 200

Laval, Québec

Canada  H7T 0B3

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 
Form 20-F £
Form 40-F Q
                                                

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): £

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): £

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

 
Yes £
 No Q
                                         
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A
 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


 
 
NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
     
Date: November 19, 2008 By:  /s/ Henri Harland
  Name:   Henri Harland
  Title:   President and Chief Executive Officer
 
                                                                                                                      
 
 
 

EXHIBIT INDEX
 

Exhibit
Description of Exhibit
99.1 Human clinical study demonstrates superior Neptune Krill Oil NKO® pharmacokinetic profile